• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Inovio Pharmaceuticals, Inc. (INO)

    -NasdaqGS
    6.01 Down 0.25(3.99%) Feb 5, 4:00PM EST
    |After Hours : 5.99 Down 0.02 (0.33%) Feb 5, 5:05PM EST
    Prev Close:6.26
    Open:6.18
    Bid:5.85 x 100
    Ask:6.30 x 200
    1y Target Est:20.20
    Beta:2.39284
    Earnings Date:Mar 14 - Mar 18 (Est.)
    Day's Range:5.96 - 6.27
    52wk Range:4.50 - 10.83
    Volume:1,908,598
    Avg Vol (3m):1,749,950
    Market Cap:433.82M
    P/E (ttm):N/A
    EPS (ttm):-0.30
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    INODown 3.99%433.82M
    PFEUp 0.10%179.22B
    AZNDown 1.44%75.92B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):12.18
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.40
    Quarterly EPS Est (Dec-15) :-0.20
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback